Post-earnings recap
Reported
Thu, Nov 7, 2024
EPS actual
$1.12
EPS est.
$1.09
EPS surprise
+2.94%
1-day move
+10.71%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report shows a positive surprise in EPS, which contributed to a significant stock increase of 10.71%. The strong performance in EPS indicates effective cost management and demand for their products. However, the lack of revenue data and future guidance leaves some uncertainty for investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.12 | N/A | +2.94% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook regarding product demand. However, they did not provide specific guidance for future quarters.
Management highlighted strong demand for their products.
They expressed confidence in maintaining operational efficiency moving forward.